Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / GNMSF - Genmab A/S reports Q2 results


GNMSF - Genmab A/S reports Q2 results

Genmab A/S (NASDAQ:GMAB): Q2 GAAP EPS of DKK4.64. Revenue of DKK1.97B (-63.9% Y/Y). Press Release The U.S. FDA accepted for Priority Review the tisotumab vedotin Biologics License Application, for patients with recurrent or metastatic cervical cancer. DARZALEX net sales increased 52% Y/Y to $2.8B in 1H2021 resulting in royalty income of DKK2.36B.

For further details see:

Genmab A/S reports Q2 results
Stock Information

Company Name: Genmab A/S Dkk
Stock Symbol: GNMSF
Market: OTC
Website: genmab.com

Menu

GNMSF GNMSF Quote GNMSF Short GNMSF News GNMSF Articles GNMSF Message Board
Get GNMSF Alerts

News, Short Squeeze, Breakout and More Instantly...